vs
Side-by-side financial comparison of Blue Foundry Bancorp (BLFY) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.
Blue Foundry Bancorp is the larger business by last-quarter revenue ($13.3M vs $9.2M, roughly 1.4× Cytosorbents Corp). Blue Foundry Bancorp runs the higher net margin — -27.4% vs -59.5%, a 32.1% gap on every dollar of revenue. On growth, Blue Foundry Bancorp posted the faster year-over-year revenue change (34.2% vs 0.9%). Over the past eight quarters, Blue Foundry Bancorp's revenue compounded faster (16.0% CAGR vs 1.3%).
Blue Foundry Bancorp is a regional bank holding company based in New Jersey, United States. It offers a comprehensive range of personal and commercial banking products, including deposit accounts, consumer loans, mortgage services, and business financing solutions, serving local individual consumers and small to medium-sized enterprises.
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
BLFY vs CTSO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $9.2M |
| Net Profit | $-3.5M | $-5.5M |
| Gross Margin | — | 73.7% |
| Operating Margin | — | -47.5% |
| Net Margin | -27.4% | -59.5% |
| Revenue YoY | 34.2% | 0.9% |
| Net Profit YoY | -30.6% | 27.4% |
| EPS (diluted) | $-0.18 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $9.2M | ||
| Q3 25 | $12.6M | $9.5M | ||
| Q2 25 | $12.0M | $9.6M | ||
| Q1 25 | $11.1M | $8.7M | ||
| Q4 24 | $9.9M | $9.2M | ||
| Q3 24 | $9.5M | $8.6M | ||
| Q2 24 | $10.1M | $8.8M | ||
| Q1 24 | $9.9M | $9.0M |
| Q4 25 | $-3.5M | $-5.5M | ||
| Q3 25 | $-1.9M | $-3.2M | ||
| Q2 25 | $-2.0M | $1.9M | ||
| Q1 25 | $-2.7M | $-1.5M | ||
| Q4 24 | $-2.7M | $-7.6M | ||
| Q3 24 | $-4.0M | $-2.8M | ||
| Q2 24 | $-2.3M | $-4.3M | ||
| Q1 24 | $-2.8M | $-6.1M |
| Q4 25 | — | 73.7% | ||
| Q3 25 | — | 70.3% | ||
| Q2 25 | — | 70.9% | ||
| Q1 25 | — | 71.1% | ||
| Q4 24 | — | 68.4% | ||
| Q3 24 | — | 61.0% | ||
| Q2 24 | — | 73.5% | ||
| Q1 24 | — | 76.5% |
| Q4 25 | — | -47.5% | ||
| Q3 25 | — | -30.2% | ||
| Q2 25 | — | -37.6% | ||
| Q1 25 | — | -44.5% | ||
| Q4 24 | — | -37.1% | ||
| Q3 24 | — | -56.1% | ||
| Q2 24 | — | -40.4% | ||
| Q1 24 | — | -51.8% |
| Q4 25 | -27.4% | -59.5% | ||
| Q3 25 | -14.8% | -33.4% | ||
| Q2 25 | -16.2% | 20.2% | ||
| Q1 25 | -24.2% | -16.9% | ||
| Q4 24 | -28.4% | -82.7% | ||
| Q3 24 | -42.7% | -32.1% | ||
| Q2 24 | -23.2% | -48.6% | ||
| Q1 24 | -28.8% | -67.7% |
| Q4 25 | $-0.18 | $-0.09 | ||
| Q3 25 | $-0.10 | $-0.05 | ||
| Q2 25 | $-0.10 | $0.03 | ||
| Q1 25 | $-0.13 | $-0.02 | ||
| Q4 24 | $-0.12 | $-0.14 | ||
| Q3 24 | $-0.19 | $-0.05 | ||
| Q2 24 | $-0.11 | $-0.08 | ||
| Q1 24 | $-0.13 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $53.1M | $6.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $312.7M | $5.9M |
| Total Assets | $2.2B | $44.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.1M | $6.2M | ||
| Q3 25 | $44.1M | $7.5M | ||
| Q2 25 | $41.9M | $10.2M | ||
| Q1 25 | $46.2M | $11.6M | ||
| Q4 24 | $42.5M | $3.3M | ||
| Q3 24 | $76.1M | $5.7M | ||
| Q2 24 | $60.3M | $8.5M | ||
| Q1 24 | $53.8M | $8.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $13.8M | ||
| Q2 24 | — | $13.7M | ||
| Q1 24 | — | $4.4M |
| Q4 25 | $312.7M | $5.9M | ||
| Q3 25 | $314.4M | $9.0M | ||
| Q2 25 | $321.3M | $11.6M | ||
| Q1 25 | $326.7M | $14.5M | ||
| Q4 24 | $332.2M | $11.1M | ||
| Q3 24 | $339.3M | $13.4M | ||
| Q2 24 | $345.6M | $17.4M | ||
| Q1 24 | $350.2M | $19.6M |
| Q4 25 | $2.2B | $44.2M | ||
| Q3 25 | $2.2B | $45.8M | ||
| Q2 25 | $2.1B | $48.0M | ||
| Q1 25 | $2.1B | $50.8M | ||
| Q4 24 | $2.1B | $47.4M | ||
| Q3 24 | $2.1B | $47.8M | ||
| Q2 24 | $2.0B | $53.4M | ||
| Q1 24 | $2.0B | $47.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.0M | $-4.8M |
| Free Cash FlowOCF − Capex | — | $-4.9M |
| FCF MarginFCF / Revenue | — | -53.4% |
| Capex IntensityCapex / Revenue | — | 1.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-12.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.0M | $-4.8M | ||
| Q3 25 | $-255.0K | $-2.6M | ||
| Q2 25 | $2.0M | $-1.5M | ||
| Q1 25 | $-3.8M | $-3.5M | ||
| Q4 24 | $5.1M | $-2.3M | ||
| Q3 24 | $-3.7M | $-2.5M | ||
| Q2 24 | $14.1M | $-4.8M | ||
| Q1 24 | $-4.9M | $-4.8M |
| Q4 25 | — | $-4.9M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | $4.9M | $-2.4M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | $-4.9M | $-4.9M |
| Q4 25 | — | -53.4% | ||
| Q3 25 | — | -27.3% | ||
| Q2 25 | — | -16.1% | ||
| Q1 25 | — | -39.7% | ||
| Q4 24 | 49.8% | -26.3% | ||
| Q3 24 | — | -30.4% | ||
| Q2 24 | — | -54.4% | ||
| Q1 24 | -49.3% | -54.2% |
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | 1.4% | 0.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | 0.1% | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.78× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLFY
Segment breakdown not available.
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
